Evidence map›Paper›PMID 42795398›Full record

ArticleLife (Basel, Switzerland)2026

Clinical Outcomes of Respiratory Syncytial Virus Versus Influenza Pneumonia in Critically Ill Adults.

Josef Yayan

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Josef YayanDepartment of Internal Medicine, Division of Pulmonary, Allergy, and Sleep Medicine, Helios University Hospital Wuppertal, Witten/Herdecke University, Heusnerstr. 40, 42283 Wuppertal, Germany.ORCID 0000-0002-8363-621X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRespiratory syncytial virus (RSV) and influenza can both cause severe viral pneumonia requiring intensive care. Influenza is supported by established vaccination programs and antiviral therapy, whereas outcomes of RSV infection among critically ill adults remain less well characterized. This study compared clinical presentation, treatment, and outcomes between ICU admissions classified as RSV pneumonia and those classified as influenza pneumonia.

methodsA retrospective cohort was assembled from MIMIC-IV data covering 2008-2019. The analytical cohort comprised 201 infection-specific ICU observations classified as RSV pneumonia (

resultsThe RSV group was older than the influenza group (66.7 vs. 59.1 years;

conclusionsRSV pneumonia was associated with higher in-hospital mortality and a longer ICU stay than influenza pneumonia in this ICU cohort. The mortality association remained after adjustment for the variables included in the primary model, although its magnitude was sensitive to model specification. Given the observational design, these findings should not be interpreted as causal. They underscore the clinical burden of severe RSV infection in adults and support further investigation in larger cohorts with standardized virological testing and measures of acute illness severity.

Indexed as

epidemiologyinfluenzain-hospital mortalityintensive care unitprognosisrespiratory infectionsrespiratory syncytial virusviral pneumonia

Identifiers

PMID42795398
PMCPMC13608524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.